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Abstract 
Background: The antimicrobial activity of silver nanoparticles (AgNP) has led to interest in their use in consumer 
products such as food contact materials, utensils, and storage containers. Incorporation of these materials into items 
intended for food processing and storage suggests that consumer use of these products could result in gastrointes-
tinal exposure to AgNP, should the nanoparticles migrate from the product. The health impact of AgNP exposure is 
unknown, especially effects related to intestinal epithelial permeability and barrier function. This study examined the 
effects of AgNP exposure of different sizes (10, 20, 75 and 110 nm) and doses (20 and 100 µg/mL) on the permeability 
of T84 human colonic epithelial cells, which serve as an in vitro model of the human gut epithelium.
Results: Results showed that effects of AgNP on the T84 epithelial cells were size- and dose-dependent, with the 
10 nm AgNP causing the most significant changes. Changes in permeability of the epithelial cell monolayer, as meas-
ured by transepithelial electrical resistance, after exposure to 10 nm AgNP were most dramatic at the highest dose 
(100 µg/mL), but also observed at the lower dose (20 µg/mL). AgNP could be visualized inside cells using transmis-
sion electron microscopy and silver was detected in basal wells using inductively coupled plasma-mass spectrometry. 
Exposure to AgNP significantly affected the expression of genes involved in anchoring tight junctions, cellular prolif-
eration and signaling, endocytosis, and cell–cell adhesion, with the 10 nm AgNP having the greatest effect.
Conclusions: The results of this study show that small-size AgNP have significant effects on intestinal permeability 
in an in vitro model of the human gastrointestinal epithelium. Such effects have the potential to compromise the 
integrity of the intestinal epithelium and this disruption of barrier function could have health consequences for the 
gastrointestinal tract.
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Background
The incorporation of engineered nanomaterials into 
industrial and consumer products is an emerging trend 
due to their unique physical and chemical properties. 
This is especially true for silver nanoparticles (AgNP), 
which have been shown to have considerable antimicro-
bial activity. Consumer products containing AgNP are 
marketed for functions such as infection control and odor 
reduction and currently include clothing, water purifica-
tion systems, biocides, appliances, and medical products 
[1–7]. There is also great interest in using AgNP in food 
packaging and other food contact materials for benefits 
such as extended shelf life and foodborne pathogen con-
trol (bacterial and viral) and items such as kitchen uten-
sils, food storage containers, cutting boards, and baby 
bottles that claim to contain AgNP are available inter-
nationally [4, 8–13]. AgNP have also been found to be 
generated by some edible decorations intended for baked 
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goods [14]. In addition, colloidal silver solutions contain-
ing AgNP are marketed as health supplements and are 
available for purchase at grocery stores and through the 
internet [2, 12, 14, 15]. This suggests that consumer use 
of these products could result in exposure of the gas-
trointestinal (GI) system to AgNP and raises questions 
about the potential health effects of such use [12].
This exposure is of particular concern because cur-
rent research continues to link more and more health 
conditions with dysfunction of the gastrointestinal tract. 
Natural processes can lead to increases in intestinal per-
meability, but permeability changes are often associ-
ated with inflammatory conditions such as autoimmune 
diseases and invasion of pathogenic microorganisms 
[16–18]. An increase in intestinal permeability often 
occurs through disruption of the tight junctions, pro-
teins that link epithelial cells together into a functional 
barrier capable of blocking the passage of microorgan-
isms and larger molecules, while allowing absorption of 
water and nutrients [16, 17]. This function is critical to a 
healthy gastrointestinal system and many conditions spe-
cifically have been linked to increased permeability of the 
gut, including Crohn’s Disease, ulcerative colitis, Type I 
diabetes, irritable bowel syndrome, GI infection, celiac 
disease, and graft-versus-host disease [16, 19]. The exact 
contribution of increased gut permeability to disease 
states is unknown, but current evidence suggests that 
increases in permeability may prompt cycles of intestinal 
inflammation, causing further increases in permeability 
and setting the GI tract on an inflammatory course that 
exacerbates disease progression [16]. As previously men-
tioned, the growing incorporation of AgNP into common 
household goods, particularly food contact materials, 
increases the likelihood of human intestinal exposure to 
such materials. Additionally, a number of studies have 
shown that exposure to AgNP may cause toxicity and 
inflammatory responses [20–23]. Therefore, there are 
legitimate concerns regarding whether the consump-
tion of AgNP could lead to increased permeability of the 
intestinal epithelium.
The purpose of this study was to perform an in  vitro 
evaluation of the effects of AgNP on the permeability 
of the intestinal epithelium as modeled by T84 cells, an 
immortalized human colonic epithelial cell line. These 
cells serve as an excellent in vitro model for the human 
gut epithelium because they both produce mucus and, 
on transwells, form polarized monolayers in which 
changes in permeability can be measured quantitatively 
[24–26]. To our knowledge, this is the first study using 
the T84 cell line to evaluate the potential gastrointestinal 
effects of silver nanomaterials. In this work, monolay-
ers of T84 cells were inoculated with two doses (20 and 
100  µg/mL) of AgNP of different sizes (10, 20, 75 and 
110  nm) to evaluate changes in paracellular permeabil-
ity and cell toxicity. Effects of AgNP exposure on cellu-
lar permeability were determined by a comprehensive 
approach examining transepithelial electrical resistance 
(TER), immunofluorescence, mRNA gene expression, 
and transmission electron microscopy (TEM). Further-
more, the ability of the silver to pass through the epithe-
lial cell monolayer was confirmed by inductively coupled 
plasma-mass spectrometry (ICP-MS).
Results
Characterization of nanoparticles and T84 monolayers
All nanoparticles were found to be sterile by plate-growth 
assay and below acceptable levels for endotoxin (<1 EU/
mL), given the concentrations of AgNP used in this study 
[27, 28]. Protein corona was assessed by comparing pro-
tein gel bands from samples eluted from cell culture-
incubated AgNP with bands from untreated cell culture 
medium. Minor protein corona formation was observed 
at the 100  µg/mL concentration on the smaller (10  and 
20  nm) AgNP, but none was observed at the 20  µg/mL 
concentration (data not shown). This suggests that the 
20  µg/mL AgNP concentration results in little protein 
adsorption and that the particles are relatively unmodi-
fied and available for biological interaction. TEM analysis 
of T84 cells grown on transwells (Fig.  1) showed polar-
ized cells with villi and the presence of cell–cell junctions 
between individual cells, demonstrating the ability of T84 
cells to form functional epithelial layers under in  vitro 
conditions.
Fig. 1 TEM image of T84 cells grown on transwells showing polarized 
cells with villi and junctions between individual cells
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Toxicity effects and cellular viability after AgNP exposure
Two distinct methods were used to evaluate cellular 
response to AgNP exposure. Cytotoxic effects of AgNP 
exposure on T84 cells were evaluated by acridine orange/
ethidium bromide staining. Viable cells stained by this 
method fluoresce green, while apoptotic and necrotic 
cells fluoresce orange–red. Stages of apoptosis can also 
be estimated from the state of chromatin in the cell 
nucleus [29, 30]. Treatment of cells for 48 h with AgNP of 
different sizes (Fig. 2b–e) showed little to no change com-
pared to control (Fig. 2a), indicating that AgNP treatment 
did not induce cell death. However, after treatment with 
100  µg/mL of silver acetate for 3  h, a number of dead/
dying cells are visible (Fig.  2f ). An image from the 3  h 
time point is shown because treatment for 48 h resulted 
in complete cell death, with very few cells still attached 
to the coverslip. Similarly, cells treated with 20 µg/mL of 
silver acetate for 48 h were almost universally in late stage 
of cell death (data not shown).
Impact of 48  h AgNP exposure on T84 cell viability 
was evaluated through use of a commercially available 
ATP-based luminescence assay. Very little effect on cell 
viability was demonstrated by treatment with AgNP at 
the 20 µg/mL dose, with the exception of the 20 nm par-
ticle. However, significant decreases in cell viability were 
observed for all AgNP sizes when cells were treated with 
Fig. 2 Acridine orange/ethidium bromide staining of T84 cell monolayers showing a control cells and cells after treatment with b 10 nm, c 20 nm, 
d 75 nm, and e 110 nm AgNP (100 µg/mL) for 48 h. T84 cells after treatment with 100 µg/mL of silver acetate (f) for 3 h are also shown
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the 100  µg/mL doses (Fig.  3). Cells treated with silver 
acetate at the lower dose showed a small, but significant, 
decrease in viability, while wells treated with 100  µg/
mL of silver acetate showed that almost no viable cells 
remained.
Effect of AgNP exposure on epithelial permeability
To measure changes in permeability, T84 cells grown on 
transwells were exposed to AgNP (10, 20, 75 and 110 nm) 
at doses 20 µg/mL (Fig. 4a) and 100 µg/mL (Fig. 4b) for 
48  h. TER measurements to assess changes in resist-
ance compared to initial reading were taken at 15  min, 
1, 2, 3, 24 and 48 h. Silver acetate at 20 and 100 µg/mL, 
in addition to EGTA, were used as controls (Fig.  4c). 
For both 20 and 100 µg/mL doses, the only tested AgNP 
that resulted in significant changes in permeability was 
the 10  nm particle. For the 20  µg/mL dose, the 10  nm 
AgNP caused significant depression of TER, indicating 
increased permeability of the cell layer, at the 48 h time 
point (p = 0.01). After exposure to the 100 µg/mL dose, 
the changes were much more dramatic, with significant 
increases in permeability observed at the 2 h (p = 0.03), 
24 h (p < 0.001), and 48 h (p < 0.001) time points. Cells 
showed increased permeability after exposure to sil-
ver acetate at both doses. Decreases in TER measure-
ments were significant for the 20 µg/mL dose at the 2, 3 
and 24  h time points. Dramatic increases in permeabil-
ity were seen for the 100  µg/mL dose at all time points 
and TER values continued to decrease over time. Cells 
exposed to EGTA, a positive control capable of induc-
ing increased permeability, showed the expected reduced 
TER measurements at 15  min, 1 and 2  h time points. 
These values gradually recovered, likely as a result of the 
compound passing from the apical compartment through 
the cell layer and becoming further diluted in basal 
media. Decreases in TER were also observed for 10 nm 
AgNP at 24 h (20 µg/mL dose) and 1 and 3 h (100 µg/mL 
dose) time points, but these results were not statistically 
significant.
Penetration of AgNP into the epithelial cell layer
Given the observed effect of AgNP on epithelial layer 
permeability, we used transmission electron microscopy 
Fig. 3 Results of ATP-based cell viability assay after treatment with 
AgNP, silver acetate, and controls for 48 h. ‘Control’ cells were treated 
only with water (negative control), while ‘Tox C’ cells were treated 
with 0.5 % hydrogen peroxide (positive control). Error bars represent 
SEM and presence of asterisk denotes significance at p < 0.05
Fig. 4 Relative changes in TER of T84 cells after exposure to AgNP-
20 µg/mL (a) AgNP-100 µg/mL (b), and controls (c). Error bars repre-
sent standard error of the mean (SEM) of 6 independent experiments
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(TEM) to see if AgNP could be observed inside T84 epi-
thelial cells after exposure. Cells were treated with AgNP 
(10 and 75  nm) and incubated for 48  h before fixation 
and imaging. Cells treated with 10 nm AgNP (50 µg/mL) 
(Fig. 5a) and 75 nm AgNP (20 µg/mL) (Fig. 5b) revealed 
potential AgNP within cells. These images showed dark 
particles with sizes approximating known AgNP size dis-
tributions. Analysis of these particles using energy dis-
persive X-ray spectroscopy (EDS) indicated the presence 
of silver, suggesting that these may be internalized AgNP 
(Additional file 1: Figure S1). Interestingly, the observed 
particles in the 10  nm AgNP sample do not appear to 
be agglomerated within the cell. Thus it appears that the 
small sized AgNP may gain entry into the cells in sin-
gle or monomeric form. In cells treated with 100 µg/mL 
doses, small amounts of silver were detected in media 
(collected from the basal compartment of transwell) by 
ICP-MS, suggesting that silver was passing through the 
cell layer from the apical compartment. No silver was 
detected in basal media of cells treated with 20  µg/mL 
doses of AgNP and silver acetate. The detected amounts 
ranged between 0.82 and 1.44  % of total spiked silver 
for the 2 h time point and 0.71–6.06 % for the 48 h time 
point (Additional file 1: Table S1). However, this method 
does not distinguish between different forms of silver, 
so it is unknown if the silver detected was in the form of 
AgNP or silver ions.
Effect of AgNP exposure on expression of molecules 
involved in barrier function
Immunofluorescence analysis of AgNP-treated cells was 
performed to determine effect on two major cellular 
adhesion molecules, Occludin (Fig.  6) and E-cadherin 
(Additional file 1: Figure S2). Occludin is one of the pri-
mary components of tight junctions and E-cadherin is an 
important component of adherens junctions in epithelial 
cells. T84 cells were treated with the 10  nm AgNP at a 
concentration of 100  µg/mL because this size and dose 
combination showed permeability increases in the TER 
data. Cells treated with EGTA and water were used as 
a positive and negative control, respectively, and cells 
treated with silver acetate (50 µg/mL) were used to assess 
the impact of silver ions. The 50 µg/mL dose was selected 
based on the results of the TER study, as the 20 µg/mL 
dose did not result in a major change in permeability at 
24 h, while the 100 µg/mL dose showed drastic increases. 
For both Occludin and E-cadherin, no significant effects 
were observed after 24  h treatment with 10  nm AgNP. 
However, slight changes in cell–cell junctions can be seen 
after silver acetate treatment. For both proteins, EGTA 
caused major disruption of cellular adhesion. Interest-
ingly, dark spots (Figs. 6b and S2B—shown with arrows) 
were consistently present in cells treated with AgNP, but 
not in any of the other controls, suggesting the presence 
of AgNP agglomerates on the monolayer surface.
Impact of AgNP exposure on expression of human cell 
junction genes
T84 epithelial cell monolayers were evaluated for changes 
in gene expression resulting from exposure to AgNP. 
Effects of 48 h exposure to 10 and 20 nm AgNP (100 µg/
mL) and silver acetate (20 µg/mL) were evaluated using 
a PCR array plate with 84 genes related to cell junctions 
and permeability. The 100 µg/mL dose was used for the 
AgNP as it was the dose at which significant effects were 
observed in the TER experiment, while the 20  µg/mL 
Fig. 5 TEM images of T84 cells with internalized nanoparticles (arrows) after exposure to a 10 nm and b 75 nm AgNP
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dose was used for the silver acetate as the cytotoxicity 
data showed that the 100 µg/mL dose caused toxicity to 
cells. The tested AgNP were also selected based on the 
TER experiment, as it was intended to compare changes 
in gene expression resulting from exposure to AgNP that 
both induced (10  nm) and did not induce (20  nm) sig-
nificant changes in permeability. Genes with significant 
changes in expression were those with p  <  0.05 when 
compared to control (Fig. 7). Of the three groups, treat-
ment with the 10  nm AgNP showed the most signifi-
cant changes in gene expression compared to treatment 
with the 20  nm AgNP or silver acetate. After exposure 
to the 10 nm AgNP, T84 cells demonstrated downregu-
lation of the Caveolin 2 (CAV2) gene and upregulation 
of Desmoglein 3, Integrin β4, Integrin β5, Junction pla-
koglobin, Notch 1 and Tight junction protein 2 (DSG3, 
ITGB4, ITGB5, JUP, NOTCH1, and TJP2) genes. Of these 
genes, DSG3 and TJP2 showed the greatest changes in 
expression, with 3.8- and 2.6-fold increases, respectively. 
Treatment with the 20 nm AgNP only resulted in signifi-
cant changes to one gene, Desmocollin 3 (DSC3), which 
was downregulated. Exposure to silver acetate (20  µg/
mL) resulted in downregulation of the CAV2 gene and 
upregulation of Integrin α9 (ITGA9). The CAV2 gene 
was the only gene demonstrating significant changes in 
expression across more than one treatment group, as it 
was downregulated in both 10 nm AgNP and silver ace-
tate groups. CAV2 was also downregulated in the 20 nm 
AgNP treatment group, but the result was not significant. 
A number of claudin genes also appeared to be affected 
by treatment with AgNP and silver acetate, although the 
result was not statistically significant. The gene expres-
sion profile clearly indicates that the pattern of changes 
in permeability caused by the silver ions is distinct from 
that caused by the AgNP.
Discussion
One of the most important functions of the gastrointes-
tinal epithelium and supporting elements, such as the 
mucus layer, is as a physical and biochemical barrier 
between the external environment present in the lumen 
and the interior of the human body [16, 31]. As such, 
the state of epithelial integrity can serve as an indica-
tor of overall gastrointestinal health. A previous study 
by our group found size and dose-dependent intestinal 
responses to AgNP in an in vivo model [32]. The present 
study is an in  vitro approach to assess if, in fact, AgNP 
toxicity is size and dose dependent in intestinal epithelial 
cells. Based on results obtained from our earlier study, a 
20 nm AgNP was added to the group of previously tested 
Fig. 6 Expression of Occludin protein in T84 cells after 24 h treatment with a control, b 10 nm AgNP, c EGTA, and d silver acetate. Arrows point to 
suspected nanoparticle agglomerates in AgNP-treated cells
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particles to further explore AgNP size-dependent effects. 
In this study, the most substantial effects on the intestinal 
epithelium were observed with the 10 nm AgNP, both in 
the permeability and gene expression analyses, compared 
to the 20, 75 and 110 nm AgNP.
In the TER experiment, changes in the intestinal cell 
epithelium permeability after exposure to 10  nm AgNP 
were seen as early as 24  h at the 20  µg/mL dose, with 
significant increases at the 48 h time point. Exposure at 
the 100  µg/mL dose caused significant increases in cel-
lular permeability, even after exposure periods as short as 
2 h. An immunofluorescence-based evaluation of Occlu-
din and E-cadherin protein expression showed little to 
no change after treatment with high-dose 10 nm AgNP, 
suggesting that the increases in permeability observed in 
this study occur by a mechanism not involving these two 
major cellular adhesion proteins. This result correlated 
well with the gene expression data, which also showed 
minimal impact of AgNP exposure on these two genes. 
Observation of monolayers by TEM after exposure to 
AgNP showed un-agglomerated nanoparticles inside of 
intestinal epithelial cells, indicating that 10  and 75  nm 
particles are capable of penetrating the epithelial cell sur-
face. Analysis of basal media after treatment of epithelial 
cell monolayers with AgNP suggests that small amounts 
of silver are capable of passing through the in  vitro cell 
layer. However, more work is needed to establish how 
permeability changes affect the movement of silver 
through the cell layer and to determine whether the pas-
saged silver is in the form of AgNP or silver ions.
In agreement with the permeability data, most sig-
nificant changes in gene expression were observed after 
exposure to the 10 nm AgNP. Exposure to 10 nm AgNP 
significantly increased expression of the tight junction 
protein-2 (TJP2) gene. This gene encodes ZO-2, a protein 
involved in anchoring tight junctions that has been shown 
to inhibit the Wnt pathway and cellular proliferation and 
promote apoptosis [33]. Therefore, the upregulation of 
this gene by 10 nm AgNP exposure suggests that this gene 
could play a role in determining cell fate upon exposure 
to small AgNP. The fact that downregulation of caveolin-2 
(CAV2), which encodes a protein integral to the formation 
of caveolae and involved in many other cellular processes, 
was strongest for silver acetate and 10  nm particles, but 
that similar effect was also observed for 20 nm particles, 
indicates that this effect may be a result of silver ion expo-
sure during treatment with silver acetate and a cumulative 
effect of ions and nanoparticles during AgNP exposure. 
Interestingly, there is evidence that CAV2 may play a 
role in the gut response to endotoxin, as CAV2-deficient 
mice were shown to be more sensitive to LPS exposure 
than wild-type mice, demonstrating more gastrointesti-
nal tissue damage and increased intestinal permeability 
[34]. Increased sensitivity to LPS as a result of decreased 
expression of CAV2 could result in altered interactions 
between host and commensal bacteria, which has been 
observed in a previous AgNP study in a rat model [32]. 
AgNP exposure also resulted in significant effect on three 
genes (DSG3, DSC3, and JUP) that encode elements of 
desmosomes, intercellular junctions that are involved in 
maintenance of strong adhesion between cells. Interest-
ingly, two of these genes were significantly upregulated 
and one was downregulated. This could indicate that cells 
treated with AgNP were attempting to compensate for the 
increased permeability by increasing the expression of 
molecules involved in cell–cell adhesion. Such a mecha-
nism could serve a protective function in vivo, serving to 
reinforce epithelial barrier integrity during AgNP expo-
sure. These observed effects of 10 nm AgNP on intestinal 
permeability are further supported by a recently pub-
lished in  vivo study that found greater silver accumula-
tion in rat tissues after oral administration of 10 nm AgNP 
than 75 and 110 nm particles. The authors suggested that 
Fig. 7 Changes in relative expression of genes related to cell–cell 
junctions and epithelial barrier function in T84 cells exposed to 10 nm 
AgNP, 20 nm AgNP, and silver acetate compared to control cells. Error 
bars represent SEM and presence of  asterisk denotes significance at 
p < 0.05
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this could be a result of 10 nm AgNP more easily pene-
trating the intestinal epithelial layer [35].
To evaluate whether cytotoxic effects of AgNP could 
be responsible for the increases in epithelial permeability 
observed during the TER study, cell toxicity as well as cell 
viability assays were utilized. We observed apparent dis-
crepancy between the staining-based cell death assay and 
the luminescence-based viability assay. These two assays 
(staining vs luminescence) measure different markers of 
cell health: the staining-based assay indicated that there 
was little or no effect of AgNP on T84 cytotoxicity, while 
the ATP-based viability assay showed a marked decrease 
in luminescence intensity for cells treated with some 
AgNP at the 100  µg/mL dose. These results could indi-
cate that the treated cells had decreased metabolic activ-
ity while remaining viable. This effect is certainly feasible, 
but the authors believe that this difference could also be 
explained by the adhesion of AgNP to the cell monolayer 
surface, which resulted in a dark deposit on the cells. This 
effect, most prominent in wells treated with small (10 and 
20 nm) AgNP at the highest dose (100 µg/mL), was pre-
sent even after removal of media from the wells and likely 
interfered with the luminescence-based assay. Similar 
effects have been observed for engineered nanomaterials 
in other assays [36]. Based on this result, staining-based 
assays may be more reliable methods to determine cellu-
lar toxicity effects of AgNP. The decrease in luminescence 
after treatment with the 10 nm AgNP at the 100 µg/mL 
dose appears to parallel the decrease in TER after the 
same treatment. However, a decrease in luminescence 
was also observed for the 20, 75 and 110 nm AgNP at the 
100 µg/mL dose and for the 20 nm AgNP at the 20 µg/
mL dose, none of which showed any significant effects in 
the TER study. Combined with the results of the staining-
based assay, which showed little cytotoxic effect of any 
AgNP exposure, these observations suggest that AgNP 
cytotoxicity is not responsible for the observed increase 
in permeability. However, cells treated with silver ace-
tate exhibited both significantly increased cell death and 
reduced cell viability, especially at the higher dose, indi-
cating that the increased permeability is likely a result of 
cytotoxic effect.
Several groups have published in  vitro cell culture-
based assessments of AgNP on intestinal epithelial cell 
lines [37–42]. Most of these studies were performed using 
the Caco-2 cell line and found varying results regarding 
cytotoxicity and impact of AgNP on epithelial cells. How-
ever, in agreement with the results of this study, most of 
these works also found that impacts on cells were size- 
and dose-dependent, with smaller-sized particles dem-
onstrating a larger effect. There is growing interest in 
developing novel in  vitro approaches to mimic in  vivo 
conditions in the GI tract. Recently, Georgantzopoulou 
et al. [42] used a co-culture method to incorporate mucus 
into a Caco-2-based system, finding that the mucus 
layer influenced AgNP toxicity effects and inflammatory 
responses in cells. As previously mentioned, one of the 
unique characteristics of T84 cells is that they produce a 
mucus layer [43], which can be visualized through Peri-
odic acid-Schiff staining of cell monolayers (Additional 
file 1: Figure S3). Throughout experimentation, our group 
observed the presence of suspected AgNP agglomer-
ates on the cell monolayer surface when viewed under a 
microscope. This is unsurprising, as it is well-documented 
that mucus binds and traps nanoparticles, especially those 
that are negatively-charged [44, 45]. Given the protec-
tive function of the mucus layer in the intestinal tract 
[46], the presence of this layer in the in vitro model likely 
mitigates some of the toxic effects of the AgNP and sil-
ver ions on the underlying cell layer. However, size has 
also been shown to be an important factor in the ability of 
nanoparticles to penetrate mucus, with smaller particles 
more likely to avoid mucoadhesion [44]. This phenom-
enon may help to explain the size-specific response seen 
in this study, in which exposure to 10 nm AgNP caused 
increased epithelial permeability while exposure to larger 
particles had no effect. This was supported by our obser-
vations, as T84 monolayers treated with 10  nm AgNP 
showed fewer, lighter cell surface agglomerates than those 
treated with 20  nm AgNP (data not shown), suggesting 
that more of the 10 nm particles may have been passing 
through the mucus layer to the epithelial surface. Regard-
less, it is clear that the presence of the mucus layer and its 
impact on AgNP exposure would more accurately reflect 
an in vivo exposure situation.
One of the most challenging aspects of research in 
this field is predicting the behavior, dispersity, and integ-
rity of AgNP in the actual gut environment. Numerous 
studies have shown that AgNP agglomerate and incur 
other physical changes in culture media and many have 
assumed that passage of nanoparticles through the GI 
tract would cause similar effects. However, a study pub-
lished by Bohmert and colleagues found that process-
ing of AgNP in an artificial digestion simulation did not 
significantly affect cytotoxicity and only caused minor 
agglomeration of particles [38]. Other studies have sug-
gested that AgNP may dissolve in the human gut envi-
ronment, or possibly dissolve and then precipitate as new 
Ag-based particles [47]. The U.S. EPA currently does not 
permit the sale of unregistered and untested food con-
tact materials containing nanoparticles [48], but their 
use is allowed for some other items and household goods 
[49]. However, AgNP-containing medical products, food 
contact materials, and supplements continue to be avail-
able in many countries and, given that increased intes-
tinal permeability has been linked to numerous health 
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conditions, it is clear that this topic deserves further 
study. Future work in this area should continue to inves-
tigate the impacts of AgNP on permeability, the behav-
ior of AgNP in the gut environment, and include studies 
that evaluate the effects of chronic, low-dose exposure on 
intestinal barrier function.
Conclusions
This study used a comprehensive approach to evaluate 
the effects of exposure to AgNP of different sizes and 
doses on intestinal permeability in an in  vitro model of 
the human gut epithelium. The in  vitro system used in 
this study, T84 human colonic epithelial cells, serve as a 
superior model for the human epithelial barrier because 
of their ability to form polarized monolayers and their 
natural production of a mucus layer. In particular, the 
presence of this adherent mucus layer allows this model 
to more accurately predict epithelial-nanoparticle inter-
actions in an in  vivo gut environment. Exposure to 
10 nm AgNP resulted in increased intestinal permeabil-
ity at both low (20 µg/mL) and high (100 µg/mL) doses, 
although effects of the higher dose were observed ear-
lier and were significantly more pronounced. Unlike the 
elevated permeability caused by treatment with the silver 
acetate controls, this increase appeared to be independ-
ent of any cytotoxicity effects. Comparable effects were 
not observed for the 20, 75 or 110  nm AgNP at either 
doses. The observation of nanoparticle-like silver bodies 
within cells and the detection of silver in basal transwell 
compartments indicate that both penetration of AgNP 
into cells and passage of AgNP or derivatives through 
the cell layer are occurring. Exposure to 10  nm AgNP 
resulted in the up-regulation of genes involved in the 
function of tight junctions and desmosomes, possibly 
indicating that cells were attempting to compensate for 
the increased permeability by increasing the expression 
of genes involved in maintaining cell–cell adhesion. The 
ability of the 10  nm AgNP to cause changes in perme-
ability and gene expression not observed with the larger 
particles could be due to an increased capacity to transit 
the protective mucus layer and penetrate the intestinal 
epithelium (Fig. 8). The results of this study suggest that 
gastrointestinal exposure to small-size silver nanoparti-
cles may cause increased intestinal permeability, even in 
the absence of any toxicity effects on cells. This has the 
potential to cause unwanted effects such as elevated gut 
inflammation and the increased passage of antigens and 
microorganisms into circulation.
Methods
Silver nanoparticles and nanoparticle characterization
All AgNP were obtained from NanoComposix (San Diego, 
CA, USA) in BioPure formulations at sizes 10, 20, 75 and 
110 nm. Three of the AgNP used in this study (10, 75 and 
110  nm) were used in previous work published by this 
group. In depth characterization of this batch of AgNP, 
including DLS, TEM, ICP-MS, and zeta-potential analysis 
was performed on these particles prior to use and charac-
terization data is available in the referenced publications 
[32, 35]. The 20 nm AgNP was obtained in identical for-
mulation to above particles and in-depth characteriza-
tion data, including analysis of size [TEM and dynamic 
light scattering (DLS)], concentration, and zeta potential, 
was provided by the company. All AgNP were spheri-
cal in shape and stabilized with a sodium citrate surface 
and were suspended in 2  mM sodium citrate solution. 
Nanoparticles (100 µL of 1 mg/mL solutions) were plated 
onto Sheep’s Blood Agar plates and incubated for 72 h at 
37  °C to confirm sterility. Nanoparticles were also tested 
using the ToxinSensor Chromogenic LAL Endotoxin 
Assay Kit (GenScript, Piscataway, NJ, USA) according to 
the manufacturer’s protocol to confirm lack of endotoxin 
contamination. Protein corona formation was tested for 
20 and 100 µg/mL concentrations of nanoparticles using 
the protocol described earlier [50]. Briefly, AgNP were 
incubated for 24 h in T84 complete cell culture medium 
and water, after which samples were removed and centri-
fuged at 13,000  rpm for 15 min. AgNP were washed 1X 
with PBS and resuspended in 30 µL sterile, distilled water. 
Novex Tris–Glycine SDS Sample Buffer (Life Technolo-
gies, Carlsbad, CA, USA) was added to suspensions and 
samples were boiled at 95  °C for 10 min. AgNP samples 
and protein ladder were loaded onto 12 % Tris–HCl and 
4–20  % Tris–HCl precast gels (Bio-Rad, Hercules, CA, 
USA) and separated using SDS-PAGE. Finally, gels were 
stained with Coomassie Blue dye and visualized. Stock 
solutions of nanoparticles were stored in the dark at 4 °C 
for the duration of the experiment.
Cell culture
T84 cells (ATCC CCL-248™), a human colorectal car-
cinoma cell line, were obtained from ATCC (Manas-
sas, VA, USA). Complete growth media was composed 
of Dulbecco’s Modified Eagle Medium (DMEM)/F-12 
media supplemented with l-glutamine and HEPES 
(ATCC, Manassas, VA, USA), with added 5  % Fetal 
Bovine Serum (FBS), Penicillin/Streptomycin, and Fungi-
zone. Cells were grown in complete media using 75 cm2 
cell culture flasks until approximately 70–80 % confluent 
and then split using 0.25 % Trypsin–EDTA into desired 
vessels. Cell cultures were maintained in a 37 °C incuba-
tor with 5 % CO2 and 95 % humidity.
Cellular toxicity/viability assays
Cellular toxicity was evaluated by acridine orange/ethid-
ium bromide staining. T84 cells were seeded onto plastic 
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coverslips and allowed to grow as described in the previ-
ous section. Cell monolayers were then treated with the 
AgNP (100 µg/mL dose) for 48 h. Wells treated with sterile, 
endotoxin-free water and silver acetate (20 and 100 µg/mL) 
were used as controls. Because of silver acetate toxicity, one 
well was also treated with 100 µg/mL of silver acetate for 
3 h to serve as comparison. After the designated treatment 
time, AgNP and media were removed from wells and cell 
monolayers were washed twice with room-temperature 
Hank’s balanced salt solution (HBSS). Fresh media was 
then replaced into all wells and acridine orange and eth-
idium bromide were added to each well (3  µg/mL final 
concentration for each). The plate was incubated at 37  °C 
for 15 min, after which coverslips were removed from the 
plate and visualized on microscope slides using an inverted 
fluorescence microscope (Life Technologies, Carlsbad, CA, 
USA). Cellular viability was assayed using the CellTiter-Glo 
Luminescent Cell Viability Assay (Promega, Madison, WI, 
USA). Briefly, T84 cells were seeded onto 96-well plates at a 
density of approximately 5 × 104 cells/well. These cells were 
allowed to grow until confluent (3–5 days) and then spiked 
with AgNP and silver acetate (20 and 100 µg/mL). Water-
treated cells served as controls and 0.5 % hydrogen perox-
ide was used as a toxicity control. After treatment for 48 h, 
media containing AgNP was removed and fresh media was 
added. The CellTiter-Glo assay was then performed using 
the manufacturer’s instructions, with the luminescence 
reading taken using a Cytation 3 Multi-Mode Reader (Bio-
Tek, Winooski, VT, USA).
Transepithelial electrical resistance
Seeding of cells and experimental measurement of tran-
sepithelial electrical resistance (TER) was performed 
according to methods established earlier [26, 51–54]. T84 
cells were plated onto 6.5  mm, PFTE, collagen-coated 
transwell inserts (Corning, Corning, NY, USA) at a con-
centration of 2.0 ×  105 cells/well. Complete cell culture 
media was added to apical and basal reservoirs and cell 
monolayers were allowed to grow for 5–10  days, with 
periodic readings of TER taken using a STX electrode 
probe and EVOM2 Epithelial Voltohmmeter (World 
Precision Instruments, Sarasota, FL, USA). Once wells 
reached approximately 800–1000 Ω, media was changed 
and cells were allowed to equilibrate for 3 h. A baseline 
TER reading was then taken, after which nanoparticles 
or controls were added. AgNP and silver acetate were 
added to wells for a final concentration of 20 and 100 µg/
mL. This range covers the concentration present in con-
sumer use products as well as a high dose (100 µg/mL) to 
establish a reference/positive control. In a separate well, 
Fig. 8 Summary of AgNP effects observed in this study. Exposure to 10 nm AgNP was shown to increase permeability of the epithelial barrier, while 
exposure to larger particles (20, 75, 110 nm) did not demonstrate any significant effects
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ethylene glycol tetraacetic acid (EGTA) at a final concen-
tration of 2.5 mM was used as a positive control to induce 
increased permeability in transwells [40]. TER measure-
ments of cells were taken before exposure to AgNP/con-
trols, as well as 15 min, 1, 2, 3, 24 and 48 h post-exposure. 
Statistical data analysis was performed using SigmaPlot 
software (Systat Software, San Jose, CA, USA) and TER 
measurements are presented as percent of original base-
line value (measured before addition of AgNP/controls). 
After completion of TER transwell studies, media from 
basal compartments was collected and stored at −20 °C 
until analysis by inductively coupled plasma mass spec-
trometry (ICP-MS) could be completed to estimate pas-
sage of silver through the cell layer. Given that there are 
many more 10 nm AgNP than 75 or 110 nm AgNP in the 
same concentration of (100 µg/mL) AgNP solution, work 
was also done to establish whether particle numbers of 
AgNP played some role in the demonstrated effect on 
permeability. In the TER experiment, differences in per-
meability were still observed when the number of 10 nm 
AgNP was adjusted to be roughly that of 110 nm AgNP 
at 100  µg/mL concentration, suggesting that effects are 
independent of particle number (data not shown).
Transmission electron microscopy
For imaging by transmission electron microscopy (TEM), 
transwell inserts of T84 cells were grown as described 
previously and spiked with AgNP and controls. After 
the 48 h time point, all cell culture media was removed 
and transwells were fixed in 4 % glutaraldehyde (Electron 
Microscopy Sciences, Hatfield, PA, USA). Fixed tissues 
were further processed as described earlier [55]. Tran-
swells were imaged at the FDA NanoCore Facility (Jeffer-
son, AR, USA) and energy-dispersive X-ray spectroscopy 
(EDS) analysis was performed to confirm the presence of 
silver within cells.
Immunofluorescence
T84 cells were seeded onto plastic coverslips (Thermo 
Fisher, Waltham, MA, USA) in a 24-well plate at a den-
sity of approximately 2.0 × 105 cells/well and incubated 
3–7  days, until cells were found to be confluent by vis-
ual observation. Cell monolayers were then treated with 
100  µg/mL of the 10  nm AgNP for 24  h. Wells treated 
with EGTA (2.5 mM), silver acetate (50 µg/mL), and an 
untreated well were used as controls. After completion 
of treatment, cell culture media was removed from wells 
and cells were washed twice with ice-cold PBS. Cells were 
fixed in a 1:1 mix of methanol and acetone for 15 min at 
room temperature. Cells were rinsed again with PBS and 
permeabilized for 3 min with 0.1 % Triton X-100 in PBS. 
Next, cells were washed twice with PBS and blocked in 
3 % milk powder for 1 h at room temperature. Cells were 
washed again (2 ×  5 min) and incubated with a mouse 
monoclonal primary antibody (15  µg/mL) overnight at 
4  °C. Primary antibodies for Occludin and E-cadherin 
were obtained from the Tight Junction Antibody Sam-
pler Pack (Invitrogen, Carlsbad, CA, USA). Cells were 
washed in PBS (4 × 5 min) and 5 µg/mL of a fluorescein-
conjugated goat anti-mouse secondary antibody solution 
was added and incubated for 1  h at room temperature, 
after which cells were washed again in PBS (4 × 5 min). 
Finally, coverslips were mounted onto microscope slides 
and visualized using an inverted fluorescence microscope 
(Life Technologies, Carlsbad, CA, USA).
QPCR analysis of cellular permeability
RNA was extracted from transwells using the PARIS 
kit (Life Technologies, Carlsbad, CA, USA) according 
to the manufacturer’s instructions. Extracted RNA was 
treated with the Turbo DNA-free kit (Life Technologies, 
Carlsbad, CA, USA) to remove contaminating DNA 
and samples were stored at −80  °C until use. The con-
centration of RNA was quantified using a NanoDrop® 
ND-1000 (NanoDrop, Wilmington, DE). RNA was 
reverse transcribed to make cDNA using the Two-Step 
Reverse Transcription TaqMan kit (Applied Biosys-
tems, Foster City, CA, USA). Gene expression analysis 
of 84 cell junction-related genes was examined using 
the RT2 Profiler PCR Array Human Cell Junction Path-
way Finder (Qiagen, Valencia, CA, USA). Plates were 
analyzed using an ABI 7500 Real-Time PCR system 
(Life Technologies, Carlsbad, CA, USA), with ampli-
fication conducted with an initial 10-min step at 95  °C 
followed by 40 cycles of 95  °C for 15  s and 60  °C for 
1 min. One independent sample was used for each plate 
and 3 plates were run for every experimental group. 
Data was analyzed using the web-based Qiagen Data 
Analysis Center with normalization of the raw data to 
provided housekeeping genes (β-ACT, β2  M, GAPDH, 
HPRT1, and RPLP0). Data from T84 cells treated with 
100  µg/mL AgNP (10 and 20  nm) and silver acetate 
(20 µg/mL) were compared to control cells treated only 
with UltraPure water (Life Technologies, Carlsbad, 
CA, USA). Changes in gene expression for RT2 Profiler 
plates were evaluated by Student’s t-test, with genes 
with p < 0.05 designated as significant.
Additional file
Additional file 1: Figure S1. Energy Dispersive Spectroscopy (EDS) 
spectra for transmission electron microscopy (TEM) images of T84 cells. 
Figure S2. Expression of E-cadherin protein in T84 cells. Figure S3. T84 
cell monolayer after Periodic acid-Schiff staining, showing presence of 
mucus layer. Table S1. Percentage of total spiked silver detected in basal 
compartment of T84 transwells after treatment with AgNP and silver 
acetate, as measured by ICP-MS.
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